Calyxt (CLXT) Stock Analysis

What Calyxt does

Calyxt, Inc. is a synthetic biology firm that engineers plant-based solutions, primarily serving the agricultural industry in the United States. The company innovates in areas such as developing easily digestible alfalfa, cultivating hemp, and producing wheat varieties with elevated fiber content. They hold an exclusive commercialization pact with S&W Seed Company to license their superior alfalfa seed across both U.S. and international markets. Established in 2010 and headquartered in Roseville, Minnesota, the entity operated as Cellectis Plant Sciences, Inc. before adopting the name Calyxt, Inc. in May 2015. Calyxt, Inc. functions as a subsidiary of Cellectis S.A.

Key metrics

ETFs linked to CLXT

Broad-market and Consumer Defensive sector ETFs an investor holding Calyxt is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CLXT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Calyxt?

Calyxt trades under the ticker CLXT on NASDAQ.

Which exchange is CLXT listed on?

CLXT is listed on NASDAQ.

What sector does Calyxt operate in?

Calyxt is classified in the Consumer Defensive sector (Packaged Foods industry).

How can PortView help analyze CLXT in a portfolio?

PortView shows CLXT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.